1. Home
  2. MLP vs FULC Comparison

MLP vs FULC Comparison

Compare MLP & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MLP

Maui Land & Pineapple Company Inc.

SELL

Current Price

$14.91

Market Cap

307.8M

Sector

Finance

ML Signal

SELL

Logo Fulcrum Therapeutics Inc.

FULC

Fulcrum Therapeutics Inc.

SELL

Current Price

$3.66

Market Cap

285.4M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
MLP
FULC
Founded
1909
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
307.8M
285.4M
IPO Year
2010
2019

Fundamental Metrics

Financial Performance
Metric
MLP
FULC
Price
$14.91
$3.66
Analyst Decision
Hold
Analyst Count
0
5
Target Price
N/A
★ $3.67
AVG Volume (30 Days)
14.0K
★ 1.4M
Earning Date
11-13-2026
10-28-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $19,457,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 68.24
N/A
52 Week Low
$13.84
$2.83
52 Week High
$19.92
$15.74

Technical Indicators

Market Signals
Indicator
MLP
FULC
Relative Strength Index (RSI) 31.24 38.55
Support Level $14.30 $3.62
Resistance Level $16.45 $3.91
Average True Range (ATR) 0.50 0.06
MACD -0.10 -0.00
Stochastic Oscillator 21.26 3.70

Price Performance

Historical Comparison
MLP
FULC

About MLP Maui Land & Pineapple Company Inc.

Maui Land & Pineapple Co Inc is a landholding and operating parent company that owns land and commercial property on the island of Maui, Hawaii. The Company puts its assets into productive use by planning, managing, developing, and selling residential, resort, commercial, agricultural, and industrial real estate. Its segments include land development and sales, which cover land planning, entitlement, development, construction, and sales of land assets; leasing, which generates revenue from real property leasing, license fees and royalties, and includes maintenance of real estate assets, conservation activities, and management of water systems in West and Upcountry Maui; and resort amenities, which include a membership program offering benefits within the Kapalua Resort.

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.

Share on Social Networks: